Gus Bilirakis (R-FL)

Priority for Pediatric Cures Act

H.R. 10359 · House bill Health

A Republican bill with 6 Democratic cosponsors · See all 9 cosponsors

Last activity — Referred to the House Committee on Energy and Commerce.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

This bill, known as the "Priority for Pediatric Cures Act," seeks to amend the Federal Food, Drug, and Cosmetic Act. The primary goal is to permanently extend the authority granted to the Secretary of Health and Human Services. This authority involves awarding priority review vouchers for rare pediatric disease products.

Yes· 3 of 5

  • Scored +7

    Would children be better off under this?

    The bill specifically targets rare pediatric diseases, which directly benefits children.

  • Scored +5

    Does this make health care easier to get in general?

    The bill incentivizes the development of treatments for rare pediatric diseases.

  • Scored +5

    Does this put more money into medical research?

    By extending vouchers, it incentivizes research into rare pediatric disease products.

The opposite

No question was scored the opposite.